How Home Workouts Change the GLP-1 Before and After
Trial and real-world data show GLP-1 results are slower and more variable than marketing suggests: 15–21% average weight loss over 68–72 weeks in trials, roughly 12% at one year for persistent real-world users, and about a quarter to two-fifths of the loss as lean tissue. This is the evidence-based timeline and the case for home resistance training as the main lever for protecting muscle and keeping the 'after' mostly fat loss.
- Citation source
- ACSM
- Evidence level
- restrained inference
The honest version of GLP-1 weight loss with home workouts before and after starts with a timeline problem. The online image usually shows two bodies and a short arrow. The studies that made these medications famous usually run closer to 68 to 72 weeks. That is not a small edit. It changes what you expect from the first month, how you judge a slow stretch in the middle, and whether you notice what kind of body mass is being lost.
This matters because GLP-1 use is no longer a niche story. Gallup reported in 2026 that about 11% of U.S. adults were currently using a GLP-1 medication, which means a lot of people are now building expectations from the same compressed before-and-after language at the same time.[1]
The first mismatch is time
The trial averages are real, and they are substantial. In STEP 1, adults taking semaglutide 2.4 mg lost an average of about 14.9% of body weight over 68 weeks, compared with 2.4% in the placebo group. In SURMOUNT-1, tirzepatide produced average losses of 15.0% to 20.9% over 72 weeks depending on dose, compared with 3.1% with placebo; 50% to 57% of participants lost at least 20% of body weight.[2]
Those are not six-week transformations. They are averages from structured trials, with ongoing treatment, follow-up, eligibility criteria, and support that do not always match a person trying to keep a job, cook dinner, manage nausea, and fit two strength sessions into a small apartment.
The more ordinary-looking data are less dramatic. A claims analysis of more than 2,400 patients reported about 1.1% average weight loss by week 8 and about 2.2% by week 72, with only about a third reaching at least 5% weight loss.[2] HealthVerity’s real-world analysis found that full-year persistent users averaged roughly 12% weight loss, below the 15% to 20% averages often cited from trials.[3]
That gap does not mean the medications “do not work” in real life. It means persistence, dose changes, side effects, access, cost, baseline health, and daily routines all show up in the final image. A before-and-after photo rarely tells you who stopped early, who paused, who changed medication, who lost appetite for training, or who kept lifting when food intake dropped.
The first 18 months are not one continuous dramatic drop
A useful GLP-1 before-and-after is less like a straight slide and more like a curve that bends. The early weeks may feel eventful because appetite changes quickly for some people, but the scale does not always move much right away. Later, the visible changes can be larger, then slower, then flatter.
| Phase | What the evidence suggests | How to read the before-and-after |
|---|---|---|
| Weeks 1–8 | Titration period; one real-world claims analysis reported about 1.1% average loss by week 8. | Visible change may be modest even when appetite has changed. |
| Months 3–6 | Trial patterns commonly move into the 5–10% range during this middle stretch. | This is often where photos begin to look more convincing, but the process is still underway. |
| Months 6–12 | Weight loss generally continues but slows. | A slower rate is expected; it is not automatically a sign that everything has failed. |
| After 12 months | Curves tend to flatten into plateau or maintenance even with continued treatment. | The “after” is often a managed state, not a finished project. |
That flattening is worth normalizing. A plateau can reflect metabolic adaptation and the body settling into a lower weight, not a sudden proof that the drug has stopped doing anything.[2] This is one reason the short-arrow before-and-after is so misleading: it removes the least glamorous part of the process, which is the long stretch where a person has to decide what habits they can repeat when novelty is gone.
What the “after” is made of
Weight lost on the scale is not one material. Some of it is fat mass. Some can be lean mass, a category that includes muscle and other fat-free tissues. The practical question is not whether lean mass can drop. It can. The better question is how much of the loss comes from lean tissue, and what part of that is reasonably modifiable.
The estimates are not tiny, but they also do not support panic framing. Reviews and body-composition analyses commonly place lean mass at roughly 25% to 40% of total weight lost during GLP-1 or incretin-based weight reduction. DXA substudies reported about 30% to 34% of the loss as lean tissue in STEP 1 and about 25% in SURMOUNT-1, with substudy sample sizes of 140 and 160 respectively. A Lancet Diabetes & Endocrinology commentary summarized fat-free-mass loss at 25% to 39% of total weight over 36 to 72 weeks, compared with 10% to 30% in caloric-restriction studies.[4]
Put plainly: a person can have a successful scale result and still finish with less muscle than they expected. That does not make the medication a bad tool. It means the “after” photo is incomplete unless it also accounts for strength, function, protein intake, and whether the person gave their muscles a reason to stay.
This is especially relevant at home, where the difference between training and not training can be quiet. No coach notices when the dumbbells stay under the bed. No gym appointment is missed. Appetite drops, meals get smaller, daily fatigue may rise, and suddenly the body is receiving fewer calories and less muscular challenge at the same time.
Activity can fall after starting a GLP-1
The home-workout piece matters partly because some people move less after starting these medications. An ENDO 2026 conference study using NIH All of Us and Fitbit data from 753 people found that daily steps dropped from 5,047 to 4,487 after GLP-1 initiation, while moderate-to-vigorous physical activity fell from 28 to 22 minutes per day.[5]
That study is a conference abstract, so it should not be stretched into a universal law. But it lines up with a common practical pattern: when appetite and intake fall, some people also unconsciously downshift movement. The American College of Sports Medicine has also reported that only about 34% of patients reach 150 minutes per week of physical activity, which is useful context even if it does not prove what any one person will do.[6]
For a person training at home, this is the place to be honest. A GLP-1 can make eating less feel possible. It does not automatically preserve leg strength, keep pulling strength, maintain glutes, or make stairs feel easier. Those adaptations come from repeated muscular work and enough nutrition to support it.
What home resistance training actually buys you
Home workouts do not make the trial averages belong to you. They do not guarantee that every pound lost is fat. They also do not need to be heroic to matter. The main job is to keep a consistent muscle-preserving signal in the week while body weight is dropping.
That signal usually comes from basic resistance patterns: squat or sit-to-stand, hinge, push, pull, carry, and trunk work. For someone in an apartment, that might mean adjustable dumbbells, one heavier dumbbell, resistance bands, a bench substitute, or bodyweight variations that can be progressed. The important part is not the equipment aesthetic. It is whether the work stays challenging enough over time that the body has a reason to keep useful tissue.
Protein belongs in the same conversation, because training without enough building material is a weak bargain. The right target depends on body size, kidney health, medication tolerance, food preferences, and medical context, so it is worth discussing with a clinician or registered dietitian rather than copying a number from a comment section. The broad principle is simpler: when intake drops, protein cannot be the first thing to disappear.
If you want the actual training structure rather than another expectations article, use the 6-week GLP-1 home workout plan as the practical companion. For a deeper look at the muscle side, the home exercise tips to protect muscle on GLP-1s are the better place to spend time. And if all you have is one dumbbell, a single-dumbbell full-body workout is closer to real life than pretending everyone has a garage gym.
How to read your own before-and-after
A useful before-and-after should include more than a starting photo and a smaller ending photo. It should make room for the calendar. If the change took 68 weeks, call it 68 weeks. If the first two months were mostly dose adjustment and habit sorting, do not judge them against a highlight reel. If the second year is mostly maintenance, that is still part of the result.
It should also make room for performance. Can you still stand from a chair without using your hands? Are your rows, presses, hinges, and carries holding steady or improving? Are daily steps collapsing while the scale drops? Those are not vanity metrics. They are clues about whether the “after” is mostly fat loss or a more mixed trade.
And it should leave space for medical reality. These medications involve prescribing decisions, side effects, contraindications, cost, and long-term planning. Weight-loss numbers from trials and claims data are useful for expectations, not for self-prescribing, changing a dose, or deciding whether to stop. Those decisions belong with your clinician.
The cleanest online GLP-1 before-and-after is usually a best-case compression of a long, uneven process. The more useful version is slower: trial averages of about 15% to 21% over 68 to 72 weeks, lower real-world averages for many users, and a meaningful share of the loss coming from lean tissue unless training and nutrition push back. At home, that pushback is not glamorous. It is a few repeatable strength sessions, enough protein, and the patience to judge the “after” by what your body can still do.
References
- GLP-1 Usage Reaches New High, Gallup, 2026.
- How long does it take to lose weight on a GLP-1 drug?, Drugs.com.
- The GLP-1 Surge: What the Real-World Data Reveals, HealthVerity.
- Rossi et al., Acta Diabetologica 2025, Acta Diabetologica, 2025.
- Maharjan Press Release ENDO 2026, Endocrine Society, 2026.
- Anti-Obesity Medications, American College of Sports Medicine.
This is general fitness education, not medical advice. For diagnosis or treatment of pain or injury, consult a qualified clinician.
Pick your next session
Browse all routines to find an appropriately-spaced next session.
Spot something off?
This content sits adjacent to health guidance — tell us if a citation or figure needs a correction.